Evidence map›Paper›PMID 38038161›Full record

ReviewInternational journal of molecular medicine2024

Potential of olfactory neuroepithelial cells as a model to study schizophrenia: A focus on GPCRs (Review).

Zuly A Sánchez-Florentino, Bianca S Romero-Martínez, Edgar Flores-Soto, Héctor Serrano, Luis M Montaño, Marcela Valdés-Tovar, Eduardo Calixto, Arnoldo Aquino-Gálvez, Germán O López-Riquelme, Ramón Alvarado and 3 more

Open access · hybridAbstract readReview
In one paragraph

Review in International journal of molecular medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Altered PLCβ/IPBiomedicines · 2024
    Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Zuly A Sánchez-FlorentinoNeuropharmacology Laboratory, Clinical Research Branch, National Institute of Psychiatry Ramón de la Fuente Muñiz, Mexico City 14370, Mexico.
Bianca S Romero-MartínezDepartment of Pharmacology, Faculty of Medicine, National Autonomous University of Mexico, Mexico City 04510, Mexico.
Edgar Flores-SotoDepartment of Pharmacology, Faculty of Medicine, National Autonomous University of Mexico, Mexico City 04510, Mexico.
Héctor SerranoDepartment of Health Sciences, Metropolitan Autonomous University Iztapalapa Unit, Mexico City 09340, Mexico.
Luis M MontañoDepartment of Pharmacology, Faculty of Medicine, National Autonomous University of Mexico, Mexico City 04510, Mexico.
Marcela Valdés-TovarDepartment of Pharmacogenetics, Clinical Research Branch, National Institute of Psychiatry Ramón de la Fuente Muñiz, Mexico City 14370, Mexico.
Eduardo CalixtoDepartment of Neurobiology, Neuroscience Research, National Institute of Psychiatry Ramón de la Fuente Muñiz, Mexico City 14370, Mexico.
Arnoldo Aquino-GálvezMolecular Biology Laboratory, Department of Pulmonary Fibrosis, National Institute of Respiratory Diseases Ismael Cosío Villegas, Mexico City 14080, Mexico.
Germán O López-RiquelmeSocioneurobiology Laboratory, Center for Research in Cognitive Sciences, Autonomous University of The State of Morelos, Cuernavaca 62209, Mexico.
Ramón AlvaradoDepartment of Physiology, Faculty of Medicine, National Autonomous University of Mexico, Mexico City 04510, Mexico.
Jesús ArguetaNeuropharmacology Laboratory, Clinical Research Branch, National Institute of Psychiatry Ramón de la Fuente Muñiz, Mexico City 14370, Mexico.
Héctor Solís-ChagoyánDepartment of Cognitive and Evolutionary Neuroscience, Center for Research in Cognitive Sciences, Autonomous University of The State of Morelos, Cuernavaca 62209, Mexico.
Bettina SommerDepartment of Research in Bronchial Hyperreactivity, National Institute of Respiratory Diseases Ismael Cosio Villegas, Mexico City 14080, Mexico.
Instituto Nacional de Psiquiatría · MXUniversidad Nacional Autónoma de México · MXUniversidad Autónoma del Estado de Morelos · MXUniversidad Autónoma Metropolitana · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Schizophrenia (SZ) is a multifactorial disorder characterized by volume reduction in gray and white matter, oxidative stress, neuroinflammation, altered neurotransmission, as well as molecular deficiencies such as punctual mutation in Disrupted‑in‑Schizophrenia 1 protein. In this regard, it is essential to understand the underlying molecular disturbances to determine the pathophysiological mechanisms of the disease. The signaling pathways activated by G protein‑coupled receptors (GPCRs) are key molecular signaling pathways altered in SZ. Convenient models need to be designed and validated to study these processes and mechanisms at the cellular level. Cultured olfactory stem cells are used to investigate neural molecular and cellular alterations related to the pathophysiology of SZ. Multipotent human olfactory stem cells are undifferentiated and express GPCRs involved in numerous physiological functions such as proliferation, differentiation and bioenergetics. The use of olfactory stem cells obtained from patients with SZ may identify alterations in GPCR signaling that underlie dysfunctional processes in both undifferentiated and specialized neurons or derived neuroglia. The present review aimed to analyze the role of GPCRs and their signaling in the pathophysiology of SZ. Culture of olfactory epithelial cells constitutes a suitable model to study SZ and other psychiatric disorders at the cellular level.

Indexed as

SchizophreniaHumansNeuroepithelial CellsNeuronsReceptors, G-Protein-CoupledStem CellsReceptors, G-Protein-CoupleddopamineglutamateG protein‑coupled receptorhuman neural stem cellolfactory epitheliumschizophreniaserotonin

Identifiers

PMID38038161
PMCPMC10712696
OpenAlexW4389086979

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.